Cumberland Pharmaceutical...

NASDAQ: CPIX · Real-Time Price · USD
4.97
-0.06 (-1.19%)
At close: May 30, 2025, 3:59 PM
4.80
-3.42%
After-hours: May 30, 2025, 04:26 PM EDT

Cumberland Pharmaceuticals Statistics

Share Statistics

Cumberland Pharmaceuticals has 14.96M shares outstanding. The number of shares has increased by -1.57% in one year.

Shares Outstanding 14.96M
Shares Change (YoY) -1.57%
Shares Change (QoQ) -0.53%
Owned by Institutions (%) 13.11%
Shares Floating n/a
Failed to Deliver (FTD) Shares 195
FTD / Avg. Volume 0.27%

Short Selling Information

The latest short interest is 78.98K, so 0.53% of the outstanding shares have been sold short.

Short Interest 78.98K
Short % of Shares Out 0.53%
Short % of Float 0.9%
Short Ratio (days to cover) 2.69

Valuation Ratios

The PE ratio is -5.14 and the forward PE ratio is -9.22. Cumberland Pharmaceuticals's PEG ratio is -1.13.

PE Ratio -5.14
Forward PE -9.22
PS Ratio 0.88
Forward PS 1.7
PB Ratio 1.46
P/FCF Ratio -42.08
PEG Ratio -1.13
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Cumberland Pharmaceuticals.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.15, with a Debt / Equity ratio of 0.9.

Current Ratio 1.15
Quick Ratio 1.03
Debt / Equity 0.9
Debt / EBITDA 112.77
Debt / FCF -25.98
Interest Coverage -11.73

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee $416,131.26
Profits Per Employee $-71,206.26
Employee Count 91
Asset Turnover 0.5
Inventory Turnover 1.65

Taxes

Income Tax -22.67K
Effective Tax Rate 0.35%

Stock Price Statistics

The stock price has increased by 235.81% in the last 52 weeks. The beta is -0.35, so Cumberland Pharmaceuticals's price volatility has been lower than the market average.

Beta -0.35
52-Week Price Change 235.81%
50-Day Moving Average 4.67
200-Day Moving Average 2.93
Relative Strength Index (RSI) 49.82
Average Volume (20 Days) 71,524

Income Statement

In the last 12 months, Cumberland Pharmaceuticals had revenue of 37.87M and earned -6.48M in profits. Earnings per share was -0.46.

Revenue 37.87M
Gross Profit 26.38M
Operating Income -7.1M
Net Income -6.48M
EBITDA 182.42K
EBIT -5.86M
Earnings Per Share (EPS) -0.46
Full Income Statement

Balance Sheet

The company has 17.96M in cash and 20.57M in debt, giving a net cash position of -2.61M.

Cash & Cash Equivalents 17.96M
Total Debt 20.57M
Net Cash -2.61M
Retained Earnings -23.97M
Total Assets 69.94M
Working Capital 6.36M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -612.19K and capital expenditures -179.71K, giving a free cash flow of -791.9K.

Operating Cash Flow -612.19K
Capital Expenditures -179.71K
Free Cash Flow -791.9K
FCF Per Share -0.06
Full Cash Flow Statement

Margins

Gross margin is 69.66%, with operating and profit margins of -18.75% and -17.11%.

Gross Margin 69.66%
Operating Margin -18.75%
Pretax Margin -17.08%
Profit Margin -17.11%
EBITDA Margin 0.48%
EBIT Margin -18.75%
FCF Margin -2.09%

Dividends & Yields

CPIX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

Currently there are no analyst rating for CPIX.

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Stock Forecasts

Scores

Altman Z-Score 1.37
Piotroski F-Score 5